1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

AVXL
Anavex Life Sciences Corp.US flagNASDAQ Global Select
2.86
USD
+0.01
- -
265.04MMarket Cap

Total Valuation

Anavex Life Sciences Corp. carries a market capitalization of 265.04M, placing it among publicly traded companies globally. Its enterprise value stands at 284.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap265.04M
Enterprise Value284.50M

Share Statistics

Anavex Life Sciences Corp. currently has 92.67M shares outstanding.

Shares Outstanding92.67M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB RatioN/A
P/TBV RatioN/A
P/FCF Ratio-9.60
P/OCF Ratio-9.60

Financial Position

Anavex Life Sciences Corp. maintains a current ratio of 41.41, meaning it holds 41.4x the short-term assets needed to cover near-term liabilities.

Current Ratio41.41
Quick Ratio41.26
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)-57.64
Return on Assets (ROA)-49.09
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Income Tax18,000.00
Effective Tax RateN/A

Stock Price Statistics

Anavex Life Sciences Corp.'s stock has declined approximately -69.57447% over the past 52 weeks. The 50-day moving average sits at 2.86, while the 200-day moving average is 3.49.

Beta (5Y)N/A
52-Week Price Change-69.57447%
50-Day Moving Average2.86
200-Day Moving Average3.49
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -32.57M, while operating income came in at -32.57M.

RevenueN/A
Gross ProfitN/A
Operating Income-32.57M
Pretax Income-28.73M
Net Income-28.75M
EBITDA-32.57M
EBIT-32.57M
Earnings Per Share (EPS)-0.33

Cash Flow

Anavex Life Sciences Corp. produced -28.22M in operating cash flow over the past twelve months.

Operating Cash Flow-28.22M
Capital ExpendituresN/A
Free Cash Flow-28.22M
FCF Per Share-0.32

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-15.53
FCF Yield-10.42

Stock Splits

Anavex Life Sciences Corp.'s most recent stock split took place on October 7, 2015 with a 4:1 split ratio.

Last Split Date10/7/2015
Split Ratio4:1

Scores

Anavex Life Sciences Corp. posts an Altman Z-Score of 108.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score108.38